1-12 of 12
atrial fibrillation
Close
Sort by
Journal Articles

Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding

Miriam Kimpton, Deborah M. Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 204–208.
https://doi.org/10.1182/hematology.2019000074
Published: 2019
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Monitoring target-specific oral anticoagulants

Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 329–333.
https://doi.org/10.1182/asheducation-2014.1.329
Published: 2014
Journal Articles

What is the effect of rivaroxaban on routine coagulation tests?

Deborah M. Siegal, Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 334–336.
https://doi.org/10.1182/asheducation-2014.1.334
Published: 2014
Journal Articles

What is the role of hemodialysis for dabigatran-associated major bleeding?

Benjamin Kim, David A. Garcia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 514–517.
https://doi.org/10.1182/asheducation-2014.1.514
Published: 2014
Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.
https://doi.org/10.1182/asheducation-2014.1.518
Published: 2014
Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.
https://doi.org/10.1182/asheducation-2013.1.464
Published: 2013
Journal Articles

Is there a role for warfarin anymore?

Alan Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 541–546.
https://doi.org/10.1182/asheducation.V2012.1.541.3798556
Published: 2012
Journal Articles

Antithrombotic therapy: triple therapy or triple threat?

Jessica Mega, Edward T. Carreras
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 547–552.
https://doi.org/10.1182/asheducation.V2012.1.547.3798919
Published: 2012
Journal Articles

Warfarin Versus New Agents: Interpreting the Data

Jack Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 221–228.
https://doi.org/10.1182/asheducation-2010.1.221
Published: 2010
Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.
https://doi.org/10.1182/asheducation-2008.1.259
Published: 2008
Journal Articles

New Anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 450–456.
https://doi.org/10.1182/asheducation-2006.1.450
Published: 2006